Putative chromaffin cell survival and enhanced host‐derived TH‐Fiber innervation following a functional adrenal medulla autograft for Parkinson's disease

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Annals of Neurology

• Publication date

  1991-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ana.410290411PMID 1681779
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Long-term evaluation of hemiparkinsonian monkeys after adrenal autografting or cavitation alone.

  1990cited by this paper
• The effect of fetal mesencephalon implants on primate MPTP-induced parkinsonism. Histochemical and behavioral studies.

  1990cited by this paper
• Does adrenal graft enhance recovery of dopaminergic neurons in Parkinson's disease?

  1990cited by this paper
• Adrenal to caudate transplantation—postmortem study

  1990cited by this paper
• NGF-like trophic support from peripheral nerve for grafted rhesus adrenal chromaffin cells.

  1990cited by this paper
• Autopsy findings in a patient who had an adrenal‐to‐brain transplant for Parkinson's disease

  1989cited by this paper
• Nerve growth factor receptor immunoreactive profiles in the normal, aged human basal forebrain: Colocalization with cholinergic neurons

  1989cited by this paper
• Clinical, biochemical, and neuropathologic findings following transplantation of adrenal medulla to the caudate nucleus for treatment of Parkinson's disease

  1989cited by this paper
• Postmortem analysis of adrenal–medulla–to–caudate autograft in a patient with parkinson's disease

  1989cited by this paper
• Adrenal medullary autografts into the basal ganglia of Cebus monkeys: injury-induced regeneration.

  1988cited by this paper
• The adrenal medullary transplant operation for Parkinson's disease: clinical observations in five patients.

  1988cited by this paper
• Transient behavioral recovery in hemiparkinsonian primates after adrenal medullary allografts.

  1988cited by this paper
• Adrenal medulla grafts enhance recovery of striatal dopaminergic fibers.

  1987cited by this paper
• Interleukin‐1

  1987cited by this paper
• Primate neostriatal neurons containing tyrosine hydroxylase: immunohistochemical evidence.

  1987cited by this paper
• Use of cryoprotectant to maintain long-term peptide immunoreactivity and tissue morphology.

  1986cited by this paper
• Interleukin-1.

  1984cited by this paper
• Adrenal medullary implants in the dopamine-denervated rat striatum. II. Acute behavior as a function of graft amount and location and its modulation by neuroleptics.

  1984cited by this paper
• Adrenal medullary implants in the dopamine-denervated rat striatum. I. Acute catecholamine levels in grafts and host caudate as determined by HPLC-electrochemistry and fluorescence histochemical image analysis.

  1984cited by this paper
• Catecholamine content of intracerebral adrenal medulla grafts.

  1983cited by this paper
• Production of prostaglandin E and an interleukin-1 like factor by cultured astrocytes and C6 glioma cells.

  1982cited by this paper
• Transplanted adrenal chromaffin cells in rat brain reduce lesion-induced rotational behaviour

  1981cited by this paper
• Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

  1981cited by this paper
• Adult rat brain astrocytes support survival of both NGF-dependent and NGF-insensitive neurones

  1979cited by this paper
• The prevention of acute gastric ulcer in the rat by alpha-methyldopa.

  1967cited by this paper
• Parkinsonism

  1967cited by this paper

• History of cellular grafting for central nervous system repair-A clinical perspective.

  2024cites this paper
• Cell-therapy for Parkinson’s disease: a systematic review and meta-analysis

  2023cites this paper
• Stem Cell-based and Advanced Therapeutic Modalities for Parkinson’s Disease: A Risk-effectiveness Patient-centered Analysis

  2022cites this paper
• Restoring Function to Dopaminergic Neurons: Progress in the Development of Cell-Based Therapies for Parkinson’s Disease

  2020cites this paper
• Strategies for bringing stem cell-derived dopamine neurons to the clinic: A European approach (STEM-PD).

  2017cites this paper
• Adrenal medulla of AS/AGU rats: a histological and immunohistochemical study.

  2017cites this paper
• La Enfermedad de Parkinson: Etiología, Tratamientos y Factores Preventivos

  2017cites this paper
• Mesenchymal Stem Cells as a Source of Dopaminergic Neurons: A Potential Cell Based Therapy for Parkinson's Disease.

  2017cites this paper
• Neuroprotection and neurorestoration as experimental therapeutics for Parkinson's disease.

  2017cites this paper
• Nogo-A Neutralization Improves Graft Function in a Rat Model of Parkinson’s Disease

  2016cites this paper
• Cell-based therapies for Parkinson disease—past insights and future potential

  2015cites this paper
• Redundant dopaminergic activity may enable compensatory axonal sprouting in Parkinson disease

  2014cites this paper
• Pulsed electromagnetic fields potentiate neurite outgrowth in the dopaminergic MN9D cell line

  2014cites this paper
• Bases farmacológicas y moleculares de las disquinesias inducidas por L-dopa en un modelo experimental de la enfermedad de Parkinson

  2014cites this paper
• Cell Therapy for Parkinson's Disease: What Next?

  2013cites this paper
• Cell Therapy for Parkinson’s Disease: Status and Perspectives

  2011cites this paper
• The Future of Cell Transplantation

  2009cites this paper
• Persistent cognitive dysfunction after traumatic brain injury: A dopamine hypothesis.

  2009cites this paper
• Cell replacement therapy for Parkinson's disease.

  2009cites this paper
• Cell-based Therapeutic Approaches for Parkinson's Disease: Progress and Perspectives

  2009cites this paper
• Pathologic findings in retinal pigment epithelial cell implantation for Parkinson disease

  2009cites this paper
• Evidence for plasticity of the dopaminergic system in Parkinsonism

  2008cites this paper
• Controversies in Stroke

  2008cites this paper
• How to Approach Alzheimer's Disease Therapy Using Stem Cell Technologies

  2008cites this paper
• Delayed increase of tyrosine hydroxylase expression in rat nigrostriatal system after traumatic brain injury.

  2007cites this paper
• Neuropathological study 16 years after autologous adrenal medullary transplantation in a Parkinson's disease patient

  2007cites this paper
• Transplantation of immortalized mesencephalic progenitors (CSM14.1 cells) into the neonatal parkinsonian rat caudate putamen

  2007cites this paper
• Transplantation of autologous sympathetic neurons as a potential strategy to restore metabolic functions of the damaged nigrostriatal dopamine nerve terminals in Parkinson's disease.

  2006cites this paper
• Dopaminergic innervation of striatal grafts placed into different sites of normal striatum: differences in the tyrosine hydroxylase immunoreactive growth pattern

  2006cites this paper
• Neural Repair Strategies for Parkinson's Disease: Insights from Primate Models

  2006cites this paper
• Transplantation in Parkinson's disease: The future looks bright.

  2006cites this paper
• A scientific rationale for protective therapy in Parkinson's disease

  2005cites this paper
• [Cell therapy and other neuroregenerative strategies in Parkinson's disease (I)].

  2005cites this paper
• An Appraisal of Ongoing Experimental Procedures in Human Spinal Cord Injury

  2005cites this paper
• Dopaminergic innervation of the human striatum in Parkinson's disease

  2005cites this paper
• Stem cell transplantation for stroke.

  2004cites this paper
• Cell Transplantation for Parkinson's Disease: Present Status

  2004cites this paper
• Heparin-binding epidermal growth factor-like growth factor: a component in chromaffin granules which promotes the survival of nigrostriatal dopaminergic neurones in vitro and in vivo.

  2004cites this paper
• Cell Transplantation for Parkinson's Disease: Present Status

  2004cites this paper
• Stem cells: do they replace or stimulate?

  2003cites this paper
• CNS regeneration: clinical possibility or basic science fantasy?

  2003cites this paper
• Cell therapy: replacement.

  2003cites this paper
• Stem cell transplantation for stroke: does it work, and if so, how?

  2003cites this paper
• Autotransplantation of Human Carotid Body Cell Aggregates for Treatment of Parkinson’s Disease

  2003cites this paper
• Fetal Tissue Transplantation for the Treatment of Parkinson’s Disease

  2003cites this paper
• Embryonic ventral mesencephalic grafts to the substantia nigra of MPTP‐treated monkeys: Feasibility relevant to multiple‐target grafting as a therapy for Parkinson's disease

  2002cites this paper
• Periwound dopaminergic sprouting is dependent on numbers of wound macrophages

  2002influential citation
• Surgical treatment for Parkinson's disease: Neural transplantation

  2002cites this paper
• Macrophages and Microglia Produce Local Trophic Gradients That Stimulate Axonal Sprouting Toward but Not beyond the Wound Edge.

  2002cites this paper
• Neurosurgery for Parkinson's disease.

  2001cites this paper
• Functional Regeneration in a Rat Parkinson's Model after Intrastriatal Grafts of Glial Cell Line-Derived Neurotrophic Factor and Transforming Growth Factor β1-Expressing Extra-Adrenal Chromaffin Cells of the Zuckerkandl's Organ

  2001cites this paper
• Neurosurgery for Parkinson's Disease

  2001cites this paper
• Cell Transplantation in the Central Nervous System

  2001cites this paper
• Influencia del tejido del nervio periférico adulto sobre la actividad regenerativa de la médula espinal previamente traumatizada Influence of adult peripheral nerve tissue on the regenerative activity of previously injured spinal cord

  2001cites this paper
• Pramipexole attenuates the dopaminergic cell loss induced by intraventricular 6-hydroxydopamine

  2000cites this paper
• Grafting of neural tissue in chronically injured spinal cord: influence of the donor tissue on regenerative activity.

  2000cites this paper
• Inhibition of brain‐derived neurotrophic factor and glial cell line‐derived neurotrophic factor expression reduces dopaminergic sprouting in the injured striatum

  2000cites this paper
• Effects of graft placement site on the survival of adrenal medulla transplants into the brain and its relation with the recovery of motor function.

  2000cites this paper
• Neural transplantation in Parkinson's disease.

  2000influential citation
• Restorative surgery of the central nervous system by means of tissue engineering using NeuroGel implants

  2000cites this paper
• Reduced BDNF mRNA expression in the Parkinson's disease substantia nigra.

  2000cites this paper
• Neural Grafting for Parkinson’s and Huntington’s Disease

  2000cites this paper
• [Embryonal nerve tissue transplantation in the therapy of Parkinson's disease: current issues].

  1999cites this paper
• Activated Macrophages and Microglia Induce Dopaminergic Sprouting in the Injured Striatum and Express Brain-Derived Neurotrophic Factor and Glial Cell Line-Derived Neurotrophic Factor

  1999influential citation
• Sprouting of dopaminergic axons after striatal injury: confirmation by markers not dependent on dopamine metabolism.

  1999cites this paper
• Clinical outcome of cotransplantation of peripheral nerve and adrenal medulla in patients with Parkinson's disease. Clínica Puerta de Hierro Neural Transplantation Group.

  1999cites this paper
• Restorative Surgical Therapies for Parkinson's Disease

  1999cites this paper
• Age‐related declines in nigral neuronal function correlate with motor impairments in rhesus monkeys

  1998cites this paper
• Topographic Factors Affecting the Functional Viability of Dopamine-Rich Grafts in the Neostriatum

  1998cites this paper
• Neuropathology of Dopaminergic Transplants in Patients with Parkinson’s Disease

  1998cites this paper
• [Neuroprotective and neurorestorative therapy in Parkinson's disease].

  1997cites this paper
• Xenogeneic Adrenal Medulla Graft Rejection Rather Than Survival Leads to Increased Rat Striatal Tyrosine Hydroxylase Immunoreactivity

  1997cites this paper
• Expression of brain-derived neurotrophic factor and TrkB neurotrophin receptors after striatal injury in the mouse.

  1997cites this paper
• Transplantation of Dopamine-Synthesizing Cells in Parkinson’s Disease: Experimental Data and Clinical Application

  1997cites this paper
• Protein from chromaffin granules promotes survival of mesencephalic dopaminergic neurons by an EGF‐receptor ligand‐mediated mechanism

  1997cites this paper
• Effect of stereotaxic intrastriatal cografts of autologous adrenal medulla and peripheral nerve in Parkinson's disease: two-year follow-up study.

  1997cites this paper
• Long-term improvement in patients with severe Parkinson's disease after implantation of fetal ventral mesencephalic tissue in a cavity of the caudate nucleus: 5-year follow up in 10 patients. Clinica Puerta de Hierro Neural Transplantation Group.

  1997cites this paper
• Neural transplantation as a therapy for Parkinson's disease.

  1997cites this paper
• Radiosurgical lesioning of the caudate nucleus as a treatment for parkinsonism: a preliminary report.

  1997cites this paper
• Cellular Therapy

  1997cites this paper
• Dopaminergic transplants in patients with Parkinson's disease: neuroanatomical correlates of clinical recovery.

  1997cites this paper
• Chromaffin cell survival and host dopaminergic fiber recovery in a patient with Parkinson's disease treated by cografts of adrenal medulla and pretransected peripheral nerve. Case report.

  1996cites this paper
• Dopaminergic sprouting in the rat striatum after partial lesion of the substantia nigra.

  1996cites this paper
• Neural transplantation and trophic factors in Parkinson's disease: special reference to chromaffin cell grafting, NGF support from pretransected peripheral nerve, and encapsulated dopamine-secreting cell grafting.

  1996cites this paper
• Clinical experience with cotransplantation of peripheral nerve and adrenal medulla in patients with Parkinson's disease

  1996cites this paper
• Parkinson's disease, trophic factors, and adrenal medullary chromaffin cell grafting: basic and clinical studies.

  1996cites this paper
• Constructing a New Nigrostriatal Pathway in the Parkinsonian Model with Bridged Neural Transplantation in Substantia Nigra

  1996cites this paper
• Functional fetal nigral grafts in a patient with Parkinson's disease: Chemoanatomic, ultrastructural, and metabolic studies

  1996cites this paper
• Chromaffin cell transplants in the CNS: Basic and clinical update

  1996cites this paper
• Fetal nigral transplantation as a therapy for Parkinson's disease.

  1996cites this paper
• Cografting with polymer-encapsulated human nerve growth factor-secreting cells and chromaffin cell survival and behavioral recovery in hemiparkinsonian rats.

  1996cites this paper
• Lessons on transplant survival from a successful model system

  1995cites this paper
• Multiple obstacles to gene therapy in the brain

  1995cites this paper
• The limitations of central nervous systemdirected gene transfer

  1995cites this paper
• Will brain tissue grafts become an important therapy to restore visual function in cerebrally blind patients

  1995cites this paper
• CNS transplant utility may surive even their hasty clinical application

  1995cites this paper
• The NGF superfamily of neurotrophins: Potential treatment for Alzheimer's and Parkinson's disease

  1995cites this paper
• The spinal cord as an alternative model for nerve tissue graft

  1995cites this paper
• Pathway rewiring with neural transplantation

  1995cites this paper
• Neural transplantation, cognitive aging and speech

  1995cites this paper